The growth of the heparin market is driven by an increase in the number of patients undergoing coronary heart disease and myocardial infarction, venous thromboembolism and cardiovascular disorders, and an aging population. Heparin is a glycosaminoglycan that occurs naturally. It is used in medicine as an anticoagulant (blood thinner). It is particularly useful in the …